Synthesis Capital logo

Synthesis Capital

Crunchbase
Crunchbase

Deals on record

1

Common Fundraising Type

Equity

Triplebar logo
Triplebar

Biotechnology

Synthesis Capital logo
The Production Board logo
Stray Dog Capital logo
iSelect Fund logo
Essential Capital logo

Triplebar is a biotechnology company that develops biological systems for manufacturing low-cost animal proteins, improving cellular meat products, and discovering therapeutic biologic drug candidates, with plans to expand their product portfolio in food and biopharmaceuticals using their Hyper-Throughput™ screening platform.

Equity
$20M
10/30/2023
Article